(R)-tert-Butyl 3-((pyridin-2-ylmethyl)amino)piperidine-1-carboxylate

Catalog No. :
ACRONP791
CAS No. :
1349702-19-7
Molecular Formula :
C16H25N3O2
Molecular Weight :
291.39

IUPAC Name:tert-butyl (R)-3-((pyridin-2-ylmethyl)amino)piperidine-1-carboxylate

(R)-tert-Butyl 3-((pyridin-2-ylmethyl)amino)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$449.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl 3-((pyridin-2-ylmethyl)amino)piperidine-1-carboxylate
IUPAC Nametert-butyl (R)-3-((pyridin-2-ylmethyl)amino)piperidine-1-carboxylate
MDL No.MFCD18917174
Molecular FormulaC16H25N3O2
Molecular Weight291.39
SMILESO=C(N1C[C@H](NCC2=NC=CC=C2)CCC1)OC(C)(C)C
InChI KeyLRSLPXWROXDKQD-CQSZACIVSA-N
Synonym(R)-tert-Butyl 3-[(pyridin-2-ylmethyl)amino]piperidine-1-carboxylate;1-Piperidinecarboxylic acid, 3-[(2-pyridinylmethyl)amino]-, 1,1-dimethylethyl ester, (3R)-
CAS No.1349702-19-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRONP791 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAGUZ427 route compound structure diagram
    ACAGUZ427188111-79-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRONP791 route product structure diagram
    ACRONP7911349702-19-7
Inquiry

2. ACRONP791 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTFCE561 route compound structure diagram
    ACTFCE56198977-36-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRONP791 route product structure diagram
    ACRONP7911349702-19-7
Inquiry

Comments (0)